1. Home
  2. BIOA

as of 07-28-2026 10:36am EST

$20.69
$0.19
-0.91%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.

Founded: 2015 Country:
United States
United States
Employees: 62 City: EMERYVILLE
Market Cap: 967.7M IPO Year: N/A
Target Price: $51.50 AVG Volume (30 days): 555.7K
Analyst Decision: Strong Buy Number of Analysts: 6
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: $4.11 - $25.95 Next Earning Date: 05-07-2026
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): 720.93% Revenue Growth (next year): -96.18%
P/E Ratio: N/A Index: N/A
Free Cash Flow: N/A FCF Growth: N/A

Share on Social Networks: